These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23356509)

  • 1. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asenapine review, part II: clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Saf; 2014 Jun; 13(6):803-30. PubMed ID: 24793161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2010 Feb; 52(1331):9-10. PubMed ID: 20216523
    [No Abstract]   [Full Text] [Related]  

  • 5. Asenapine: a less effective, yet, more dangerous neuroleptic!
    Prescrire Int; 2012 Oct; 21(131):229-32. PubMed ID: 23185842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine: a review of acute and extension phase data in bipolar disorder.
    McIntyre RS
    CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asenapine for the treatment of bipolar disorder.
    Marazziti D; Mucci F; Falaschi V; Dell'Osso L
    Expert Opin Pharmacother; 2019 Aug; 20(11):1321-1330. PubMed ID: 31132287
    [No Abstract]   [Full Text] [Related]  

  • 9. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
    Reyad AA; Mishriky R
    Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
    Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
    Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.
    McIntyre RS
    Expert Rev Neurother; 2010 May; 10(5):645-9. PubMed ID: 20420486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
    Sawyer L; Azorin JM; Chang S; Rinciog C; Guiraud-Diawara A; Marre C; Hansen K
    J Med Econ; 2014 Jul; 17(7):508-19. PubMed ID: 24720805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ▼Asenapine for bipolar I disorder?
    Drug Ther Bull; 2012 Jun; 50(6):69-72. PubMed ID: 22700206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
    Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine: a new antipsychotic option.
    Henry JM; Fuller MA
    J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
    Gerrits M; de Greef R; Peeters P
    Biopharm Drug Dispos; 2010 Jul; 31(5-6):351-7. PubMed ID: 20549835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Asenapine in bipolar disorder: efficacy, safety and place in clinical practice].
    Samalin L; Tixeront C; Llorca PM
    Encephale; 2012 Jun; 38(3):257-65. PubMed ID: 22726414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.